Centene ( (CNC) ) has issued an update.
On May 6, 2025, Centene Corporation’s senior management will meet with investors to reaffirm their 2025 earnings guidance, maintaining a GAAP diluted EPS floor of greater than $6.19 and an adjusted diluted EPS floor of greater than $7.25. The company emphasizes the use of non-GAAP financial measures to provide a clearer picture of its core operations, cautioning that these metrics may differ from those of other companies, and encourages a comprehensive review of its financial statements.
Spark’s Take on CNC Stock
According to Spark, TipRanks’ AI Analyst, CNC is a Outperform.
Centene’s strong financial performance and valuation metrics underpin its potential as an investment, with significant revenue growth and effective cost management strategies. However, technical indicators show a bearish trend, and challenges such as high medical expenses and specialty drug costs present ongoing risks. The recent board appointment is a positive strategic move, adding expertise to navigate complex industry challenges.
To see Spark’s full report on CNC stock, click here.
More about Centene
Centene Corporation operates in the healthcare industry, providing a wide range of services primarily focused on government-sponsored healthcare programs. The company is a significant player in managed care services, offering products that include Medicaid, Medicare, and health insurance marketplace services.
YTD Price Performance: -1.21%
Average Trading Volume: 4,879,230
Technical Sentiment Signal: Buy
Current Market Cap: $29.94B
See more insights into CNC stock on TipRanks’ Stock Analysis page.